Login to Your Account



In The Clinic NEWS
In 2012, the Agency for Healthcare Research and Quality (AHRQ) set out to develop the Registry of Patient Registries (RoPR) as a one-stop repository of information about patient registries focused on, but not exclusive to, U.S.-based registries.
BUT THERE'S BACKUP
Boehringer Ingelheim (BI) GmbH's clinical hold on the oral beta secretase (BACE) inhibitor BI 1181181 for Alzheimer's disease (AD) because of skin reactions in some patients put a dent in shares of partner Vitae Pharmaceuticals Inc., but if worse comes to worse, the pair can move on to a different, structurally distinct candidate in the same class that's ready for testing.
Abivax SAS dosed the first patient in a pivotal phase IIb/III trial of ABX203, a therapeutic vaccine it's testing against hepatitis B virus (HBV) e-antigen-negative active chronic HBV.
More In The Clinic Headlines

Cast Your Vote

Has biotech’s bubble burst?: